ÂÜÀòÂÒÂ×

Jingyi Song is a seasoned business development analyst with extensive experience across various industries, including biotechnology, data analytics, and international trade. Currently at Pluri since May 2021, Jingyi has contributed to developing competitive databases and financial models supporting allogeneic cell therapy and immunotherapy. Previous roles include data analyst at Signals Analytics and business analyst at Qlarium Technologies, where Jingyi built risk assessment systems. Jingyi also co-founded Shawoom and held managerial positions at Velocity Consulting and PepsiCo China, where responsibilities encompassed business intelligence, account management, and sales analysis. Jingyi holds a Bachelor's degree in Business Administration from Shanghai Normal University.